Categories Earnings Call Transcripts, Preliminary Transcripts, Technology
Bottomline Technologies, Inc. (EPAY) Q4 2021 Earnings Call Transcript
EPAY Earnings Call - Final Transcript
Bottomline Technologies, Inc. (NASDAQ: EPAY) Q4 2021 earnings call dated Aug. 10, 2021
Corporate Participants:
Angela White — Vice President of Investor Relations
Rob Eberle — Chief Executive Officer
Bruce Bowden — Chief Financial Officer
Analysts:
Andrew Schmidt — Citigroup — Analyst
James Rush — Craig-Hallum Capital Group LLC — Analyst
Gary Prestopino — Barrington Research — Analyst
Kyle Peterson — Needham and Company, LLC — Analyst
Cristopher Kennedy — William Blair & Company LLC — Analyst
John Rodriguez — D.A. Davidson Companies — Analyst
Presentation:
Operator
Greetings. Welcome to Bottomline Technologies Fourth Quarter and Fiscal Year 2021 Financial Results. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.
I will now turn the call over to your host, Angela White, Vice President of Investor Relations. Thank you. You may begin.
Disclaimer
This transcript is produced by AlphaStreet, Inc. While we strive to produce the best transcripts, it may contain misspellings and other inaccuracies. This transcript is provided as is without express or implied warranties of any kind. As with all our articles, AlphaStreet, Inc. does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company’s SEC filings. Neither the information nor any opinion expressed in this transcript constitutes a solicitation of the purchase or sale of securities or commodities. Any opinion expressed in the transcript does not necessarily reflect the views of AlphaStreet, Inc.
© COPYRIGHT 2021, AlphaStreet, Inc. All rights reserved. Any reproduction, redistribution or retransmission is expressly prohibited.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
